Sai Parenteral's

Not Rated
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
619.85
-3.85 (-0.62%)
BSENSE

Jul 03, 03:30 PM

BSE+NSE Vol: 3.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024

Compare Profit and Loss Results of Sai Parenteral's
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
124.00
1,283.00
-1,159.00
-90.34%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
124.00
1,283.00
-1,159.00
-90.34%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
39.00
-39.00
-100.00%
Raw Materials Consumed
73.00
587.00
-514.00
-87.56%
Power & Fuel Cost
2.00
94.00
-92.00
-97.87%
Employee Cost
10.00
211.00
-201.00
-95.26%
Operating Expenses
1.00
67.00
-66.00
-98.51%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
24.00
-23.00
-95.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
20.00
-16.00
-80.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
97.00
1,079.00
-982.00
-91.01%
Operating Profit (PBDIT) excl Other Income
26.00
203.00
-177.00
-87.19%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
27.00
212.00
-185.00
-87.26%
Interest
7.00
114.00
-107.00
-93.86%
Profit before Depriciation and Tax
19.00
98.00
-79.00
-80.61%
Depreciation
5.00
99.00
-94.00
-94.95%
Profit Before Taxation & Exceptional Items
14.00
-1.00
15.00
1,500.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
-1.00
15.00
1,500.00%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
10.00
-1.00
11.00
1,100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
-316.00
336.00
106.33%
Profit Available for appropriations
30.00
-317.00
347.00
109.46%
Appropriations
30.00
-317.00
347.00
109.46%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.89
-0.27
4.16
1,540.74%
Profit And Loss - Net Sales
Net Sales 124.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

Profit And Loss - Interest
Interest 7.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024